Quantum Biopharma (QNTM) Research & Development (2020 - 2026)

Quantum Biopharma has disclosed Research & Development across 7 years of filings, most recently posting $387428.0 for Q2 2026.

• In Q2 2026, Research & Development fell 29.46% year-over-year to $387428.0; the TTM figure through Jun 2026 stood at $1.6 million (down 49.1% YoY), while the FY2025 annual figure was $2.8 million, down 54.58% from the prior year.
• Research & Development came in at $387428.0 for Q2 2026 at Quantum Biopharma, down from $626092.0 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $2.7 million in Q4 2022 to a low of $32985.0 in Q3 2023.
• Average Research & Development over 5 years is $977624.9, with a median of $685447.0 recorded in 2024.
• Year-over-year, Research & Development slumped 98.23% in 2023 and soared 2158.0% in 2024.
• Over 5 years, Research & Development stood at $2.7 million in 2022, then slumped by 42.69% to $1.5 million in 2023, then slumped by 89.62% to $160260.0 in 2024, then plunged by 56.07% to $70404.0 in 2025, then jumped by 450.29% to $387428.0 in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $387428.0 in Q2 2026, $626092.0 in Q1 2026, and $70404.0 in Q4 2025.